Table 1.
List of S-nitrosylated proteins involved in diverse brain disorders.
Protein | Disease | Sites of SNO modification | Experimental models | Suggested molecular/biological consequences of S-nitrosylation | Reference | ||
---|---|---|---|---|---|---|---|
Calcineurin | ASD | – | Mice | Inhibition of the phosphatase activity | [19] | ||
Syntaxin 1a | ASD | – | Mice | Enhanced binding with SNARE complex | [19] | ||
mGluR7 | ASD | – | Mice | Increase of Ca2+ influx in presynaptic neurons | [19] | ||
RNF213 | AD | – | Mice | Inhibition of the ligase activity | [122] | ||
Drp1 | AD, HD | Cys-644 | Human, mice, cell lines | Increase the rate of mitochondrial fission | [130,178] | ||
Cdk-5 | AD | Cys-83 and Cys-157 | Human, mice, cell lines | Hyperactivation of the kinase activity | [125,126] | ||
PSD 95 | AD | Cys-3 and Cys-5 | Animal, cell lines | Blocks translocation of the protein | [205] | ||
IDE | AD | Cys-110 and Cys 819 | Cell lines | Inhibition of the metalloprotease activity | [9,18,206] | ||
ApoE | AD | Cys-112 | Human, cell lines | Reduction of affinity to LDL receptors | [136,207] | ||
MEF2 | AD | Cys-39 | Human, mice, cell lines | Reduction of the binding affinity to DNA | [41] | ||
Aldolase C, fructose bisphosphate | AD | – | Human | Reduction of the metalloprotease activity | [137] | ||
MAP1B | AD | Cys-2457 | Mice, cell lines | Enhancement of the binding affinity with microtubules | [36,208] | ||
Carbonic anhydrase-II (CAH-II) | AD | – | Human | Reduction of the enzymatic activity leading to protein accumulation | [209] | ||
Caspases | AD | Cys-163 | Human cell lines | Decline in protease activity | [9,210] | ||
GSK3β | AD | Cys-76, cys-199, cys-317 | Mice, cell lines | Inhibition of the kinase activity and increased translocation into nucleus | [119] | ||
XIAP | PD, AD, HD | – | Human, mice, cell lines | Inhibition of the anti-apoptotic function | [150] | ||
GAPDH | AD, ALS, cerebral ischemia, PD | Cys-150, cys-152 | Human, mice, cell line | Enhancement of the binding with Siah complex and activation of p300/CBP resulting in the increased neuronal death | [33,183,184] | ||
Parkin | PD | – | Human, mice, cell lines | Autoubiquitination and degradation. | [147,152] | ||
DJ-1 | PD | Cys-46, cys-53, cys106 | Human, cell lines | Reduction of the antioxidant activity | [148,211] | ||
PTEN | PD, AD | Cys-83 | Human, cell lines | Reduction of the phosphatase activity | [148] | ||
PDI | PD, ALS | – | Human, mice, cell line | Inhibition of the dithiol isomerase activity | [133,149] | ||
Prx2 | PD | Cys-51, cys-172 | Human, cell lines | Inhibition of the antioxidant activity | [151] | ||
Huntingtin | HD | – | Mice, cell lines | Protein aggregate formation leading to cell death | [174] | ||
NMDAR | AD, Prion disease | Cys −744, cys-798 | Animal | Inhibition of the receptor activity and NO production | [9,18,212] | ||
MMP9 | Cerebral ischemia | – | Animal, cell lines | Reduction of the metalloprotease activity | [213] | ||
PLP | MS | – | Animal | Conformational and functional alteration | [195,204] |